Description
SWOT ANALYSIS OF TEVA PHARMACEUTICALS
Teva Pharmaceutical
Parent Company
Teva Pharmaceutical
Category
Pharmaceutical
Sector
Health Care
Tagline/ Slogan
Live your life; We make quality healthcare accessible around the world
They are largest generic drug maker in the world. They make quality USP healthcare accessible around the world
STP
Segment
Generic , branded products and API
Target Group
Healthcare professionals & pharmacists.
Teva is the largest generic manufacturing company. They specialize in development, manufacturing & marketing of branded and generic Positioning products.
SWOT Analysis
1. Teva has presence in 60 countries & employs over 46,000 well trained people 2. No.1 generic company in the world with substantial market share 3. Has broadest portfolio of over 1300 molecules in generics 4. Holds patent for world’s largest selling multiple sclerosis drug Copaxone Strength 5. One of the 15 largest pharmaceutical companies worldwid
1. Discontinued production of major anesthetic drugs 2. Teva gets sustantial revenue from outside U.S which is subjected to Weakness macro-economic fluctuations
1. Consolidation of Taiyo acquisition 2. Increasing generic market Opportunity 3. Patents of major drugs are on the verge of expiry
Threats
1.Stringent marketing & manufacturing regulations
2. Disruption of global supply chain due to changing environment 3. More resourceful companies entering generics market
Competition
1. Abbott laboratories 2. Merck 3. Acadia pharmaceuticals Competitors 4. Bayer
doc_461433049.docx
SWOT ANALYSIS OF TEVA PHARMACEUTICALS
Teva Pharmaceutical
Parent Company
Teva Pharmaceutical
Category
Pharmaceutical
Sector
Health Care
Tagline/ Slogan
Live your life; We make quality healthcare accessible around the world
They are largest generic drug maker in the world. They make quality USP healthcare accessible around the world
STP
Segment
Generic , branded products and API
Target Group
Healthcare professionals & pharmacists.
Teva is the largest generic manufacturing company. They specialize in development, manufacturing & marketing of branded and generic Positioning products.
SWOT Analysis
1. Teva has presence in 60 countries & employs over 46,000 well trained people 2. No.1 generic company in the world with substantial market share 3. Has broadest portfolio of over 1300 molecules in generics 4. Holds patent for world’s largest selling multiple sclerosis drug Copaxone Strength 5. One of the 15 largest pharmaceutical companies worldwid
1. Discontinued production of major anesthetic drugs 2. Teva gets sustantial revenue from outside U.S which is subjected to Weakness macro-economic fluctuations
1. Consolidation of Taiyo acquisition 2. Increasing generic market Opportunity 3. Patents of major drugs are on the verge of expiry
Threats
1.Stringent marketing & manufacturing regulations
2. Disruption of global supply chain due to changing environment 3. More resourceful companies entering generics market
Competition
1. Abbott laboratories 2. Merck 3. Acadia pharmaceuticals Competitors 4. Bayer
doc_461433049.docx